lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Rezolute, Inc.
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
April 21, 2026
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
March 24, 2026
Rezolute to Participate in the Citizens Life Sciences Conference
March 4, 2026
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
February 20, 2026
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026